公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2022 | Changing epidemiology of liver disease in Asia: Dual infection of HBV and HCV | CHUN-JEN LIU ; PEI-JER CHEN | Liver International | 12 | 9 | |
2023 | Characterization of Hepatitis B Virus in Tenofovir-Treated and Untreated Chronically Infected Mothers and Their Immunoprophylaxis Failure Infants | HONG-YUAN HSU ; HUEY-LING CHEN ; Chiang, Cheng-Lun; Lai, Ming-Wei; Mu, Shu-Chi; Wen, Wan-Hsin; Cheng, Shao-Wen; Hu, Jen-Jan; KAI-CHI CHANG ; CHIEN-NAN LEE ; CHUN-JEN LIU ; JIA-FENG WU ; YEN-HSUAN NI ; MEI-HWEI CHANG | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 3 | 2 | |
2009 | Characterization of interleukin 8 in woodchucks with chronic hepatitis B and hepatocellular carcinoma | CHUN-JEN LIU ; Huang Y.-J.; HUEY-LING CHEN ; Lin H.-T.; Lin H.-L.; Kuo M.-L.; Huang J.-L.; DING-SHINN CHEN ; PEI-JER CHEN ; Wu H.-L. | Genes and Immunity | 4 | 5 | |
2016 | Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model | Li Y.-T.; CHUN-JEN LIU ; TUNG-HUNG SU ; Cheng H.-R.; YUNG-MING JENG ; Lin H.-L.; Wang C.-C.; JIA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN ; Wu H.-L. | Oncotarget | 4 | 4 | |
2019 | Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma | TUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; SHANG-JU WU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 29 | 26 | |
2023 | Chronic hepatitis B with concurrent metabolic dys-function-associated fatty liver disease: Challenges and perspectives | SHANG-CHIN HUANG ; CHUN-JEN LIU | Clinical and Molecular Hepatology | 9 | 7 | |
2014 | Circulating programmed death-1 as a marker for sustained high hepatitis b viral load and risk of hepatocellular carcinoma e95870 | Cheng H.-Y.; Kang P.-J.; YA-HUI CHUANG ; Wang Y.-H.; Jan M.-C.; Wu C.-F.; Lin C.-L.; CHUN-JEN LIU ; Liaw Y.-F.; Lin S.-M.; PEI-JER CHEN ; Lee S.-D.; MING-WHEI YU | PLoS ONE | 65 | 25 | |
2021 | Clinical and histologic features of patients with biopsy-proven metabolic dysfunction-associated fatty liver disease | SHANG-CHIN HUANG ; Su H.-J; JIA-HORNG KAO ; TAI-CHUNG TSENG ; HUNG-CHIH YANG ; TUNG-HUNG SU ; PEI-JER CHEN ; CHUN-JEN LIU | Gut and Liver | 38 | 32 | |
2014 | Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously | Cheng H.-R.; JIA-HORNG KAO ; Wu H.-L.; Chen T.-C.; TAI-CHUNG TSENG ; CHEN-HUA LIU ; TUNG-HUNG SU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU | Liver International | 13 | 11 | |
2003 | Clinical aspects and outcomes of volunteer blood donors testing positive for hepatitis-C virus infection in Taiwan: A prospective study | CHUN-JEN LIU ; PEI-JER CHEN ; Shau W.-Y.; JIA-HORNG KAO ; Lai M.-Y.; DING-SHINN CHEN | Liver International | 24 | 22 | |
2016 | Clinical characteristics and long-term outcome of acute kidney injury in patients with HBV-related acute-on-chronic liver failure | Shi X.; Zhu P.; Yan G.; CHUN-JEN LIU ; Zhang C.; Huang G.; Zhang Y.; Yan Z.; Wang Y. | Journal of Viral Hepatitis | 14 | 13 | |
2017 | Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients | Lee M.-H.; Huang C.-F; Lai H.-C; Lin C.-Y; Dai C.-Y; CHUN-JEN LIU ; Wang J.-H; Huang J.-F; Su W.-P; HUNG-CHIH YANG ; Kee K.-M; Yeh M.-L; Chuang P.-H; SHIH-JER HSU ; Huang C.-I; JIA-HORNG KAO ; CHIEH-CHANG CHEN ; Chen S.-H; Jeng W.-J; Yang H.-I; Yuan Y; Lu S.-N; Sheen I.-S; CHEN-HUA LIU ; Peng C.-Y; Yu M.-L; Chuang W.-L; Chen C.-J. | Scientific Reports | 16 | 14 | |
2023 | Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective | TUNG-HUNG SU ; CHIH-HORNG WU ; TSUNG-HAO LIU ; CHENG-MAW HO ; CHUN-JEN LIU | Clinical and molecular hepatology | 8 | 6 | |
2014 | Clinical presentations of patients from different age cohorts with biliary tract stone diseases | Hu K.-C.; Wang H.-Y.; Chang W.-H.; Chu C.-H.; Lin S.-C.; CHUN-JEN LIU ; MING-SHIANG WU ; Shih S.-C. | Journal of Gastroenterology and Hepatology (Australia) | 10 | 7 | |
2014 | Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy | TUNG-HUNG SU ; CHUN-JEN LIU ; HUNG-CHIH YANG ; YUNG-MING JENG ; Cheng H.-R; CHEN-HUA LIU ; TAI-CHUNG TSENG ; THAI-YEN LING ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology | 16 | 14 | |
2015 | Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection | Cheng H.-R.; JIA-HORNG KAO ; Wu H.-L; TAI-CHUNG TSENG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU | Hepatology International | 14 | 11 | |
2011 | The clinical significance of occult hepatitis B transfusion in Taiwan - a look-back study | TUNG-HUNG SU ; PEI-JER CHEN ; Chen T.-C.; Cheng H.-R.; Li L.; Lin K.-S.; JIA-HORNG KAO ; DING-SHINN CHEN ; CHUN-JEN LIU | Transfusion Medicine | 30 | 26 | |
2006 | Clinical significance of occult hepatitis B virus infection cannot be overlooked [11] | CHUN-JEN LIU ; JIA-HORNG KAO ; DING-SHINN CHEN | Clinical Infectious Diseases | 1 | 1 | |
2007 | Clinicopathological differences between hepatitis B viral genotype B- and C-related resectable hepatocellular carcinoma | Lin C.-L.; Chen J.-D.; CHUN-JEN LIU ; PO-HUANG LEE ; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Viral Hepatitis | 23 | 21 | |
2017 | Combination therapy for chronic hepatitis B: Current updates and perspectives | TUNG-HUNG SU ; CHUN-JEN LIU | Gut and Liver | 19 | 15 |